Shelby Wilkinson
Consultant, New Product Planning & Business Development at Cabaletta Bio - Philadelphia, PA, US
Shelby Wilkinson's Colleagues at Cabaletta Bio
Shelby Wilkinson's Contact Details
267-759-3100
Greater Boston
Cabaletta Bio
Shelby Wilkinson's Company Details
Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases. The CABA™ platform, in combination with Cabaletta Bio's proprietary technology, has advanced a growing pipeline that currently includes potential treatments for patients with mucosal pemphigus vulgaris, MuSK-associated myasthenia gravis, PLA2R-associated membranous nephropathy, mucocutaneous pemphigus vulgaris and hemophilia A with FVIII alloantibodies. Cabaletta Bio's headquarters are located in Philadelphia, PA. For more information, visit www.cabalettabio.com.